术前阿片类药物使用是关节镜下肩袖修复术后翻修手术、并发症及资源利用增加的危险因素
基于MarketScan理赔数据库2009至2018年214283例关节镜下肩袖修复患者,按术前6个月日均口服吗啡当量(OME)分为未用阿片及<1、1-<5、5-<10、≥10 OME/日组。术前阿片使用与90天并发症和3年翻修手术风险升高相关,且呈剂量依赖性;日均≥10 OME者3年翻修手术比值比为2.03(95%CI 1.62-2.54;P<.001)。
要点
- 术前日均≥10 OME者3年翻修手术风险约为未用阿片者的2.03倍(95%CI 1.62-2.54;P<.001)。
- 术前日均≥1 OME者3年翻修手术、再手术和感染率均升高。
- 所有术前阿片使用组住院和术后急诊就诊率均高于未用阿片组。
核心结论
- 术前阿片类药物使用是关节镜下肩袖修复术后并发症和翻修手术的危险因素,并观察到阿片使用与术后并发症之间存在剂量依赖性关系。
研究设计与样本
- 队列研究,证据等级3级;利用MarketScan理赔数据库识别2009至2018年接受关节镜下肩袖修复的患者。
- 按术前6个月日均口服吗啡当量(OME)将患者分为未用阿片、<1、1-<5、5-<10和≥10 OME/日组。
- 共纳入214283例患者,采用二项逻辑回归和广义线性模型比较各组90天并发症和3年翻修手术率。
主要发现
- 214283例患者中,50.7%术前未接受阿片类药物,7.7%、26.8%、6.3%和8.6%分别在6个月期间日均接受<1、1-<5、5-<10和≥10 OME。
- 并发症随术前OME升高而增加;多因素分析显示,日均使用≥1 OME的患者3年翻修手术、再手术和感染率均升高。
- 日均≥10 OME者与未用阿片者相比,翻修手术比值比为2.03(95%CI 1.62-2.54;P<.001),即比值增加103%。
- 所有阿片使用组的住院率和术后急诊就诊率均高于未用阿片组。
- 与未用阿片者相比,阿片使用组术前6个月和术后3个月医疗费用的校正差异范围为1307至5820美元(P<.001)。
关键数值与推荐
- 日均≥10 OME者3年翻修手术比值比为2.03(95%CI 1.62-2.54;P<.001),对照为未用阿片者。
- 日均≥1 OME者3年翻修手术、再手术和感染率升高。
- 阿片使用组与未用阿片组术前6个月和术后3个月医疗费用校正差异为1307至5820美元(P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies have shown preoperative opioid use to influence outcomes after various surgical procedures. Researchers have not assessed this relationship after rotator cuff repair (RCR). HYPOTHESIS/PURPOSE: The purpose was to assess the relationship between preoperative opioid use and outcomes after arthroscopic RCR. We hypothesized that patients prescribed higher daily averages of preoperative oral morphine equivalents (OMEs) would show increased rates of 90-day complications and 3-year revision surgery. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: The MarketScan claims database was utilized to identify patients who underwent arthroscopic RCR between 2009 and 2018. We used preoperative opioid use status to divide patients into groups based on the average daily OMEs consumed in the 6 months before surgery: opioid-naïve, <1, 1-<5, 5-<10, and ≥10 OMEs per day. We retrieved 90-day complication and 3-year revision surgery rates. Opioid use groups were then compared with binomial logistic regression and generalized linear models. RESULTS: We identified 214,283 patients. Of those patients, 50.7% did not receive any preoperative opioids, while 7.7%, 26.8%, 6.3%, and 8.6% received <1, 1-<5, 5-<10, and ≥10 OMEs per day over a 6-month time period, respectively. Complications increased with increasing preoperative OMEs. Multivariate analysis revealed that any patient using ≥1 OME per day had increased rates of 3-year revision surgery, reoperations, and infections. Specifically, patients averaging ≥10 OMEs per day showed a 103% (odds ratio, 2.03 [95% CI, 1.62-2.54]; P < .001) increase in the odds of revision surgery compared with opioid-naïve patients. Rates of hospital admissions and postoperative emergency department encounters were higher in all opioid use groups. Adjusted differences in 6-month preoperative and 3-month postoperative health care costs were seen in the opioid use groups compared with opioid-naïve patients, ranging from US$1307 to US$5820 (P < .001). CONCLUSION: Preoperative opioid use was a risk factor for complications and revision surgery after arthroscopic RCR. We also observed a dose-dependent response between opioid use and postoperative complications.
引用
- Farley KX, Wilson JM, Spencer CC, et al. Preoperative Opioid Use Is a Risk Factor for Revision Surgery, Complications, and Increased Resource Utilization After Arthroscopic Rotator Cuff Repair. Am J Sports Med. 2020. PMID: 33030963. doi:10.1177/0363546520960122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。